Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, multicentrická studie
Grantová podpora
339407
European Research Council - International
PubMed
29788237
PubMed Central
PMC6113703
DOI
10.1093/ecco-jcc/jjy068
PII: 4999332
Knihovny.cz E-zdroje
- Klíčová slova
- Genetics and molecular epidemiology, TNGS, VEO-IBD, monogenic disorders, paediatrics,
- MeSH
- dítě MeSH
- idiopatické střevní záněty diagnóza etiologie terapie MeSH
- kohortové studie MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- prediktivní hodnota testů MeSH
- předškolní dítě MeSH
- věk při počátku nemoci MeSH
- vysoce účinné nukleotidové sekvenování * MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
BACKGROUND AND AIMS: An expanding number of monogenic defects have been identified as causative of severe forms of very early-onset inflammatory bowel diseases [VEO-IBD]. The present study aimed at defining how next-generation sequencing [NGS] methods can be used to improve identification of known molecular diagnosis and to adapt treatment. METHODS: A total of 207 children were recruited in 45 paediatric centres through an international collaborative network [ESPGHAN GENIUS working group] with a clinical presentation of severe VEO-IBD [n = 185] or an anamnesis suggestive of a monogenic disorder [n = 22]. Patients were divided at inclusion into three phenotypic subsets: predominantly small bowel inflammation, colitis with perianal lesions, and colitis only. Methods to obtain molecular diagnosis included functional tests followed by specific Sanger sequencing, custom-made targeted NGS, and in selected cases whole exome sequencing [WES] of parents-child trios. Genetic findings were validated clinically and/or functionally. RESULTS: Molecular diagnosis was achieved in 66/207 children [32%]: 61% with small bowel inflammation, 39% with colitis and perianal lesions, and 18% with colitis only. Targeted NGS pinpointed gene mutations causative of atypical presentations, and identified large exonic copy number variations previously missed by WES. CONCLUSIONS: Our results lead us to propose an optimised diagnostic strategy to identify known monogenic causes of severe IBD.
Bioinformatics Platform Imagine Institute Paris France
Centro Hospitalar Gaia Espinho Department of Paediatrics Vila Nova de Gaia Portugal
Collège de France Médecine expérimentale Paris France
Department of Gastroenterology Hôpital St Antoine Assistance Publique Hôpitaux de Paris Paris France
Department of Paediatrics Centre Hospitalier du Mans Le Mans France
Department of Paediatrics Centre hospitalier régional universitaire Hôpital Clocheville Tours France
Department of Paediatrics Centre Hospitalo Universitaire Charles Nicolle Rouen France
Department of Paediatrics Centre Hospitalo Universitaire de St Etienne St Etienne France
Department of Paediatrics Centre Hospitalo Universitaire de Strasbourg Strasbourg France
Department of Paediatrics Centre Hospitalo Universitaire Sud Réunion St Pierre France
Department of Paediatrics Centro Hospitalar São João Porto Portugal
Department of Paediatrics Hopital La Marsa Tunisia
Department of Paediatrics Hôpital Mongi Slim La Marsa Tunisia
Department of Paediatrics Hospital of Messina University of Messina Messina Italy
Department of Paediatrics Universitätsklinikum Hamburg Hamburg Germany
Department of Paediatrics University General Hospital of Thessaloniki Thessaloniki Greece
Department of Woman Child and General and Specialized Surgery 2nd University of Naples Naples Italy
Genomic Platform Imagine Institute Paris France
Hospital Regional Universitario de Málaga Departamento de Pediatría Malaga Spain
Hvidovre University Hospital Department of Paediatrics Copenhagen Denmark
Inflammatory Bowel Disease Unit Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
INSERM UMR 1163 and Imagine Institute Paris France
INSERM UMR 1163 Translational Genetic and Imagine Institute Paris France
INSERM UMR1163 Immunogenetics of Paediatric Autoimmunity and Imagine Institute Paris France
INSERM UMR1163 Laboratory of Intestinal Immunity and Imagine Institute Paris France
INSERM UMR1163 Lymphocyte activation and EBV susceptibility and Imagine Institute Paris France
Leiden University Medical Centre Department of Paediatrics Leiden The Netherlands
MRE Bethesda Gyermekkórháza; Department of Pediatrics Budapest Hungary
Paediatric Gastroenterology Hepatology and Nutrition Gazi University Ankara Turkey
Semmelweis University; Department of Paediatrics Budapest Hungary
Shaare Zedek Medical Centre Jerusalem Israel
St Marien Hospital Bonn Germany
Unit of Paediatric Nutrition Hospital Universitario 12 de Octubre Madrid Spain
Université Paris Descartes Sorbonne Paris Cité Paris France
University Hospital Hradec Kralove Czech Republic
Zobrazit více v PubMed
Kammermeier J, Drury S, James CT, et al. . Targeted gene panel sequencing in children with very early onset inflammatory bowel disease – evaluation and prospective analysis. J Med Genet 2014;51:748–55. PubMed
Picard C, Fischer A. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur J Immunol 2014;44:2854–61. PubMed
Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut 2013;62:1795–805. PubMed
Glocker EO, Kotlarz D, Boztug K, et al. . Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033–45. PubMed PMC
Glocker EO, Frede N, Perro M, et al. . Infant colitis – it’s in the genes. Lancet 2010;376:1272. PubMed
Begue B, Verdier J, Rieux-Laucat F, et al. . Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol 2011;106:1544–55. PubMed
Pigneur B, Escher J, Elawad M, et al. . Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group. Inflamm Bowel Dis 2013;19:2820–8. PubMed
Verbsky JW, Chatila TA. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked [IPEX] and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr 2013;25:708–14. PubMed PMC
Stoddard JL, Niemela JE, Fleisher TA, Rosenzweig SD. Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front Immunol 2014;5:531. PubMed PMC
Lo B, Zhang K, Lu W, et al. . AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 2015;349:436–40. PubMed
Uhlig HH, Schwerd T, Koletzko S, et al. ; COLORS in IBD Study Group and NEOPICS. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 2014;147:990–1007.e3. PubMed PMC
Nijman IJ, van Montfrans JM, Hoogstraat M, et al. . Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol 2014;133:529–34. PubMed
Yu H, Zhang VW, Stray-Pedersen A, et al. . Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing. J Allergy Clin Immunol 2016;138:1142–51.e2. PubMed
Petersen BS, August D, Abt R, et al. . Targeted gene panel sequencing for early-onset inflammatory bowel disease and chronic diarrhea. Inflamm Bowel Dis 2017;23:2109–20. PubMed
Canani RB, Castaldo G, Bacchetta R, Martín MG, Goulet O. Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies. Nat Rev Gastroenterol Hepatol 2015;12:293–302. PubMed PMC
Malamut G, Verkarre V, Suarez F, et al. . The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010;105:2262–75. PubMed
Flanagan SE, Haapaniemi E, Russell MA, et al. . Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet 2014;46:812–4. PubMed PMC
Haapaniemi EM, Kaustio M, Rajala HL, et al. . Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood 2015;125:639–48. PubMed PMC
Milner JD, Vogel TP, Forbes L, et al. . Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 2015;125:591–9. PubMed PMC
Kuehn HS, Ouyang W, Lo B, et al. . Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014;345:1623–7. PubMed PMC
Schubert D, Bode C, Kenefeck R, et al. . Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014;20:1410–6. PubMed PMC
Alangari A, Alsultan A, Adly N, et al. . LPS-responsive beige-like anchor [LRBA] gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 2012;130:481–8.e2. PubMed PMC
Li H, Handsaker B, Wysoker A, et al. ; 1000 Genome Project Data Processing Subgroup. The sequence alignment/map format and SAMtools. Bioinformatics 2009;25:2078–9. PubMed PMC
Sherry ST, Ward MH, Kholodov M, et al. . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001;29:308–11. PubMed PMC
Auton A, Brooks LD, Durbin RM, et al. ; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 2015;526:68–74. PubMed PMC
Lek M, Karczewski KJ, Minikel EV, et al. ; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016;536:285–91. PubMed PMC
Adzhubei IA, Schmidt S, Peshkin L, et al. . A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–9. PubMed PMC
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073–81. PubMed
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014;11:361–2. PubMed
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014;46:310–5. PubMed PMC
Itan Y, Shang L, Boisson B, et al. . The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods 2016;13:109–10. PubMed PMC
Fabre A, Breton A, Coste ME, et al. . Syndromic [phenotypic] diarrhoea of infancy/tricho-hepato-enteric syndrome. Arch Dis Child 2014;99:35–8. PubMed
Salomon J, Goulet O, Canioni D, et al. . Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form. Hum Genet 2014;133:299–310. PubMed
Charbit-Henrion F, Jeverica AK, Bègue B, et al. ; GENIUS Group. Deficiency in mucosa-associated lymphoid tissue lymphoma translocation 1: a novel cause of IPEX-like syndrome. J Pediatr Gastroenterol Nutr 2017;64:378–84. PubMed
Moes N, Rieux-Laucat F, Begue B, et al. . Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010;139:770–8. PubMed
Aguilar C, Lenoir C, Lambert N, et al. . Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol 2014;134:1131–41.e9. PubMed
Bakhtiar S, Ruemmele F, Charbit-Henrion F, et al. . Atypical manifestation of LPS-responsive beige-like anchor deficiency syndrome as an autoimmune endocrine disorder without enteropathy and immunodeficiency. Front Pediatr 2016;4:98. PubMed PMC
Germán-Díaz M, Rodriguez-Gil Y, Cruz-Rojo J, et al. . A new case of congenital malabsorptive diarrhea and diabetes secondary to mutant neurogenin-3. Pediatrics 2017, Jul 19. doi: 10.1542/peds.2016-2210. [Epub ahead of print.] PubMed DOI
Romberg N, Al Moussawi K, Nelson-Williams C, et al. . Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 2014;46:1135–9. PubMed PMC
Coelho R, Peixoto A, Amil-Dias J, et al. . Refractory monogenic Crohn’s disease due to X-linked inhibitor of apoptosis deficiency. Int J Colorectal Dis 2016;31:1235–6. PubMed
Parlato M, Charbit-Henrion F, Hayes P, et al. . First identification of biallelic inherited DUOX2 inactivating mutations as a cause of very early onset inflammatory bowel disease. Gastroenterology 2017;153:609–11.e3. PubMed
Parlato M, Charbit-Henrion F, Pan J, et al. . Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis. EMBO Mol Med 2018; 10. doi: 10.15252/emmm.201708483. PubMed DOI PMC